Concurrent Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Concurrent Investment Advisors's LLY Position: Q3 2026 in Review
Concurrent Investment Advisors increased its Eli Lilly (LLY) stake by 36% in Q3 2026, buying an estimated $20.1M and bringing the position to 63,892 shares worth $73.9M. The position accounts for 0.51% of the portfolio, ranked #28.
Concurrent Investment Advisors first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. 4,631 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Concurrent Investment Advisors held 63,892 shares of Eli Lilly worth $73.9M as of Q3 2026.
- Concurrent Investment Advisors bought 17,056 Eli Lilly shares in Q3 2026, an estimated $20.1M.
- Eli Lilly made up 0.51% of Concurrent Investment Advisors's portfolio in Q3 2026, its #28 holding.
- Concurrent Investment Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
- 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Concurrent Investment Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.